Literature DB >> 1835534

Establishment of long term cell lines from 2 patients with large granular lymphocyte lymphocytosis displaying an unusual phenotype.

D Scott-Algara1, F Vuillier, C Dauguet, G Dighiero.   

Abstract

Two long-term cell lines obtained from two cases of large granular lymphocyte lymphocytosis (LGLL) displaying an unusual phenotype are reported here. Patient n. 1 was CD2+ CD3- CD16+ CD8+ CD56- CD57- CD29+ CD45RA+, whereas patient n. 2 was CD2-CD3+ CD8+ CD16+ CD56- CD57+ CD29+ CD45RA+. The cells were large granular lymphocytes by light and electron microscopic criteria and displayed strong antibody-dependent cell mediated cytotoxicity (ADCC) and NK activity. Northern blot analysis revealed aberrant transcripts of TCR beta chains for patient n. 1, and full length TCR alpha and beta transcripts for patient n. 2. In both cases, we were able to establish a long term cell line which functionally revealed strong ADCC and NK activity. Functional implications of these 2 subpopulations are discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1835534

Source DB:  PubMed          Journal:  Nouv Rev Fr Hematol


  2 in total

1.  Clinicobiological, immunophenotypic, and molecular characteristics of monoclonal CD56-/+dim chronic natural killer cell large granular lymphocytosis.

Authors:  Margarida Lima; Julia Almeida; Andrés García Montero; Maria dos Anjos Teixeira; Maria Luís Queirós; Ana Helena Santos; Ana Balanzategui; Alexandra Estevinho; Maria del Cármen Algueró; Paloma Barcena; Sónia Fonseca; Maria Luís Amorim; José Manuel Cabeda; Luciana Pinho; Marcos Gonzalez; Jesus San Miguel; Benvindo Justiça; Alberto Orfão
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

2.  Natural killer (NK) cell activity during HIV infection: a decrease in NK activity is observed at the clonal level and is not restored after in vitro long-term culture of NK cells.

Authors:  D Scott-Algara; F Vuillier; A Cayota; G Dighiero
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.